Cargando…

Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis

BACKGROUND: Contrast-induced nephropathy (CIN) is increasingly seen in patients receiving contrast medium. Abelmoschus manihot (L.) Medik. (Malvaceae) and its preparations are widely used and effective in the treatment of various chronic kidney diseases and CIN in China. It is supposed to be an impo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhongchi, Qian, Lichao, Niu, Ruge, Wang, Yibei, Yang, Ying, Liu, Chunling, Lin, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479589/
https://www.ncbi.nlm.nih.gov/pubmed/37675022
http://dx.doi.org/10.3389/fneph.2022.834513
_version_ 1785101624154259456
author Xu, Zhongchi
Qian, Lichao
Niu, Ruge
Wang, Yibei
Yang, Ying
Liu, Chunling
Lin, Xin
author_facet Xu, Zhongchi
Qian, Lichao
Niu, Ruge
Wang, Yibei
Yang, Ying
Liu, Chunling
Lin, Xin
author_sort Xu, Zhongchi
collection PubMed
description BACKGROUND: Contrast-induced nephropathy (CIN) is increasingly seen in patients receiving contrast medium. Abelmoschus manihot (L.) Medik. (Malvaceae) and its preparations are widely used and effective in the treatment of various chronic kidney diseases and CIN in China. It is supposed to be an important adjuvant therapy for CIN. METHODS: PubMed and CNKI were searched for the main compounds of A. manihot L. The Swiss target prediction platform, OMIM, GeneCards, DisGeNET, and DrugBank databases were mined for information relevant to the prediction of targets that A. manihot L. in the treatment of CIN. Subsequently, STRING database was applied for the construction of the PPI protein interaction network, meanwhile, the core targets were screened. DAVID database was used to perform the GO function and Kegg signal pathway enrichment analysis. AutoDockTools and PYMOAL were used for molecular docking. Vitro experiments were used to verify the effect of TFA, the main active component of A. manihot L., in the intervention of iopromide-induced cells injury. RESULTS: A total of 17 chemical components and 133 potential targets in A. manihot L. were obtained. The top 15 proteins with higher degree value were selected from the PPI network model, AKT1, PIK3R1, EGFR, SRC,AR, APP, TNF, GAPDH, MMP9, and PTPN1, etc. may be core targets. The enrichment analysis indicated that A. manihot L. was involved in the regulation of PI3K/AKT signaling pathway, FoxO signaling pathway, VEGF signaling pathway, HIF-1, TNF signaling pathway, melanoma, hepatitis B, and other signaling pathways which were mainly associated with the regulation of transcription and apoptosis, protein phosphorylation, inflammatory response, aging, and cell proliferation. Molecular docking indicated that the key components and core targets had a good binding ability. The vitro experiments illustrated that TFA reduces iopromide induced renal tubular cell injury and apoptosis, which may be related to regulating the phosphorylation of AKT. CONCLUSION: The study preliminarily revealed the multi-component, multi-target, and multi-pathway synergistic effects of A. manihot L. on CIN, which provide theoretical reference and basis for the study of the pharmacological mechanism of A. manihot L. in the treatment of CIN.
format Online
Article
Text
id pubmed-10479589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104795892023-09-06 Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis Xu, Zhongchi Qian, Lichao Niu, Ruge Wang, Yibei Yang, Ying Liu, Chunling Lin, Xin Front Nephrol Nephrology BACKGROUND: Contrast-induced nephropathy (CIN) is increasingly seen in patients receiving contrast medium. Abelmoschus manihot (L.) Medik. (Malvaceae) and its preparations are widely used and effective in the treatment of various chronic kidney diseases and CIN in China. It is supposed to be an important adjuvant therapy for CIN. METHODS: PubMed and CNKI were searched for the main compounds of A. manihot L. The Swiss target prediction platform, OMIM, GeneCards, DisGeNET, and DrugBank databases were mined for information relevant to the prediction of targets that A. manihot L. in the treatment of CIN. Subsequently, STRING database was applied for the construction of the PPI protein interaction network, meanwhile, the core targets were screened. DAVID database was used to perform the GO function and Kegg signal pathway enrichment analysis. AutoDockTools and PYMOAL were used for molecular docking. Vitro experiments were used to verify the effect of TFA, the main active component of A. manihot L., in the intervention of iopromide-induced cells injury. RESULTS: A total of 17 chemical components and 133 potential targets in A. manihot L. were obtained. The top 15 proteins with higher degree value were selected from the PPI network model, AKT1, PIK3R1, EGFR, SRC,AR, APP, TNF, GAPDH, MMP9, and PTPN1, etc. may be core targets. The enrichment analysis indicated that A. manihot L. was involved in the regulation of PI3K/AKT signaling pathway, FoxO signaling pathway, VEGF signaling pathway, HIF-1, TNF signaling pathway, melanoma, hepatitis B, and other signaling pathways which were mainly associated with the regulation of transcription and apoptosis, protein phosphorylation, inflammatory response, aging, and cell proliferation. Molecular docking indicated that the key components and core targets had a good binding ability. The vitro experiments illustrated that TFA reduces iopromide induced renal tubular cell injury and apoptosis, which may be related to regulating the phosphorylation of AKT. CONCLUSION: The study preliminarily revealed the multi-component, multi-target, and multi-pathway synergistic effects of A. manihot L. on CIN, which provide theoretical reference and basis for the study of the pharmacological mechanism of A. manihot L. in the treatment of CIN. Frontiers Media S.A. 2022-04-22 /pmc/articles/PMC10479589/ /pubmed/37675022 http://dx.doi.org/10.3389/fneph.2022.834513 Text en Copyright © 2022 Xu, Qian, Niu, Wang, Yang, Liu and Lin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nephrology
Xu, Zhongchi
Qian, Lichao
Niu, Ruge
Wang, Yibei
Yang, Ying
Liu, Chunling
Lin, Xin
Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
title Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
title_full Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
title_fullStr Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
title_full_unstemmed Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
title_short Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
title_sort mechanism of abelmoschus manihot l. in the treatment of contrast-induced nephropathy on the basis of network pharmacology analysis
topic Nephrology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479589/
https://www.ncbi.nlm.nih.gov/pubmed/37675022
http://dx.doi.org/10.3389/fneph.2022.834513
work_keys_str_mv AT xuzhongchi mechanismofabelmoschusmanihotlinthetreatmentofcontrastinducednephropathyonthebasisofnetworkpharmacologyanalysis
AT qianlichao mechanismofabelmoschusmanihotlinthetreatmentofcontrastinducednephropathyonthebasisofnetworkpharmacologyanalysis
AT niuruge mechanismofabelmoschusmanihotlinthetreatmentofcontrastinducednephropathyonthebasisofnetworkpharmacologyanalysis
AT wangyibei mechanismofabelmoschusmanihotlinthetreatmentofcontrastinducednephropathyonthebasisofnetworkpharmacologyanalysis
AT yangying mechanismofabelmoschusmanihotlinthetreatmentofcontrastinducednephropathyonthebasisofnetworkpharmacologyanalysis
AT liuchunling mechanismofabelmoschusmanihotlinthetreatmentofcontrastinducednephropathyonthebasisofnetworkpharmacologyanalysis
AT linxin mechanismofabelmoschusmanihotlinthetreatmentofcontrastinducednephropathyonthebasisofnetworkpharmacologyanalysis